Healwell AI Inc.
No enriched coverage for $HWAIF in the last 7 days.
No SEC Form 4 filings for $HWAIF in the last 30 days.
See all $HWAIF insider activity →HEALWELL AI, through its subsidiary Intrahealth, has deployed SMART Summary, an AI-powered clinical summarization tool, across New Brunswick. The technology integrates with the Profile EMR platform, reducing clinicians' time on chart review. SMART Summary is now available to 400+ clinicians, with plans for broader adoption. The company is traded on the TSX (AIDX) and OTCQX (HWAIF).
HEALWELL AI (TSX: AIDX) and WELL Health (TSX: WELL) announced that WELLTRUST, a database of consented patients, has surpassed 100,000 consents. HEALWELL's DARWEN AI platform matches trial protocols with this patient population, aiming to streamline clinical trial recruitment. Both companies plan to scale the program, targeting one million consents and international expansion.
HEALWELL AI Inc. (TSX:AIDX, OTCQX:HWAIF) reported Q2-2026 revenue from continuing operations of $33.0 million, roughly flat vs. $33.2 million in Q2-2025. Six-month revenue rose to $66.2 million from $41.2 million, driven by the Orion Health acquisition. Operating cash flow was $4.5 million positive. The company valued its indirect SpaceX stake at about CAD$23 million and targets ~10% Adjusted EBITDA margin by year-end.
Recent HWAIF coverage spans technology and earnings.
HEALWELL AI, through its subsidiary Intrahealth, has deployed SMART Summary, an AI-powered clinical summarization tool, across New Brunswick. The technology integrates with the Profile EMR platform, reducing clinicians' time on chart review. SMART Summary is now available to 400+ clinicians, with plans for broader adoption. The company is traded on the TSX (AIDX) and OTCQX (HWAIF).
HEALWELL AI (TSX: AIDX) and WELL Health (TSX: WELL) announced that WELLTRUST, a database of consented patients, has surpassed 100,000 consents. HEALWELL's DARWEN AI platform matches trial protocols with this patient population, aiming to streamline clinical trial recruitment. Both companies plan to scale the program, targeting one million consents and international expansion.
HEALWELL AI Inc. (TSX:AIDX, OTCQX:HWAIF) reported Q2-2026 revenue from continuing operations of $33.0 million, roughly flat vs. $33.2 million in Q2-2025. Six-month revenue rose to $66.2 million from $41.2 million, driven by the Orion Health acquisition. Operating cash flow was $4.5 million positive. The company valued its indirect SpaceX stake at about CAD$23 million and targets ~10% Adjusted EBITDA margin by year-end.
AlphAI scores every news story that mentions HWAIF with an AI model for sentiment and relevance, and aggregates insider trades from Healwell AI Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
HEALWELL AI, through its subsidiary Intrahealth, has deployed SMART Summary, an AI-powered clinical summarization tool, across New Brunswick. The technology integrates with the Profile EMR platform, reducing clinicians' time on chart review. SMART Summary is now available to 400+ clinicians, with plans for broader adoption. The company is traded on the TSX (AIDX) and OTCQX (HWAIF).
2 min readHEALWELL AI (TSX: AIDX) and WELL Health (TSX: WELL) announced that WELLTRUST, a database of consented patients, has surpassed 100,000 consents. HEALWELL's DARWEN AI platform matches trial protocols with this patient population, aiming to streamline clinical trial recruitment. Both companies plan to scale the program, targeting one million consents and international expansion.
2 min readHEALWELL AI Inc. (TSX:AIDX, OTCQX:HWAIF) reported Q2-2026 revenue from continuing operations of $33.0 million, roughly flat vs. $33.2 million in Q2-2025. Six-month revenue rose to $66.2 million from $41.2 million, driven by the Orion Health acquisition. Operating cash flow was $4.5 million positive. The company valued its indirect SpaceX stake at about CAD$23 million and targets ~10% Adjusted EBITDA margin by year-end.
6 min read